PR Newswire SAN DIEGO, Oct. 28, 2024 Results from VENTURE Phase 2 Study of Subcutaneous VK2735 in Obese Patients and Phase 1 Trial of Oral VK2735 in Healthy Subjects to be Presented SAN DIEGO, Oct. 28, 2024 /PRNewswire/ -- Viking ...
PR Newswire EAGAN, Minn., Oct. 24, 2024 Real-world study of GLP-1 patients continues to deliver leading insights EAGAN, Minn., Oct. 24, 2024 /PRNewswire/ -- In the latest findings from its industry-leading study, Prime Therapeutics ...
PR Newswire TORONTO, Oct. 22, 2024 In this free webinar, learn about how obesity and diabetes drug development requires monitoring for hypoglycemia with a blood glucose meter (BGM) for regulatory submission. Attendees will learn how GLP-1 ...
PR Newswire OXFORD, England, Oct. 15, 2024 OXFORD, England, Oct. 15, 2024 /PRNewswire/ -- Genomics' latest groundbreaking research, showcased at the Bupa Health Symposium, shows that a person's genetic background is a key driver for their ...
PR Newswire WEBSTER, Texas, Oct. 15, 2024 WEBSTER, Texas, Oct. 15, 2024 /PRNewswire/ -- The Primary Care Center of Clear Lake is proud to announce that two of its physicians, Dr. Smriti Choudhary and Dr. Niraj Choudhary, have been certified ...
PR Newswire MILAN, Oct. 9, 2024 MILAN, Oct. 9, 2024 /PRNewswire/ -- Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-jae Lee) announced on the 9th that they will present their cutting-edge drug delivery technologies, including the ...
PR Newswire ST. LOUIS, Oct. 3, 2024 New Intensive Weight Loss Program for Mercy Patients ST. LOUIS, Oct. 3, 2024 /PRNewswire/ -- Mercy received a nearly $3 million funding award from the Patient-Centered Outcomes Research Institute ...
PR Newswire SALT LAKE CITY, Oct. 2, 2024 SALT LAKE CITY, Oct. 2, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral ...
PR Newswire CHARLOTTESVILLE, Va. and SAN FRANCISCO, Sept. 30, 2024 – Results from the placebo-controlled study in patients with obesity-related heart failure with preserved ejection fraction (HFpEF) were presented in a Late Breaking Clinical ...
PR Newswire CAMBRIDGE, Mass., Sept. 30, 2024 Data Revealed Favorable Safety, Tolerability and Dose-Linear Pharmacokinetics (PK) Top-Line Data Readout from the MAD Part 2 Expected in the First Quarter of 2025 Planned Phase 1 Part 3 ...
Understanding how brain chemistry and food decisions are linked to rising obesity and related health issues.
Study finds a 50% rise in overweight and obesity among adolescents in England, increasing from 22% in 2008–2010 to 33% in 2021–2023.
The increasing use of GLP-1 medications for weight loss is leading to significant changes in food preferences, with users consuming less processed foods, soda, and certain meats.
Losing a lot of weight provides long-term health benefits, even if some weight is regained.
A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers